Trials / Sponsors / Verve Therapeutics, Inc.
Verve Therapeutics, Inc.
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia Hypercholesterolemia, Hypertriglyceridemia, Refractory Hyperlipidemia | Phase 1 | 2024-10-30 |
| Enrolling By Invitation | Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Dise Atherosclerotic Cardiovascular Disease, Heterozygous Familial Hypercholesterolemia, Hypercholesterolemia | — | 2024-06-09 |
| Recruiting | A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease Heterozygous Familial Hypercholesterolemia, Premature Coronary Heart Disease | Phase 1 | 2024-04-30 |
| Completed | A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease Heterozygous Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia | Phase 1 | 2022-07-05 |